» Articles » PMID: 11606496

Interleukin 1B and Interleukin 1RN Polymorphisms Are Associated with Increased Risk of Gastric Carcinoma

Overview
Specialty Gastroenterology
Date 2001 Oct 19
PMID 11606496
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Interleukin (IL)-1 gene cluster proinflammatory polymorphisms have been associated with development of gastric atrophy and with increased risk of gastric carcinoma. We aimed to determine the association between IL-1 loci polymorphisms and increased risk of gastric carcinoma in samples from a Portuguese population, and to find whether there was any relationship with the histologic types of gastric carcinoma.

Methods: In a case-control study including 220 controls and 152 patients with gastric carcinoma (intestinal, 76; diffuse, 37; and atypical, 39), both the IL-1B-511 biallelic polymorphism and the IL-1RN penta-allelic variable number of tandem repeats were genotyped.

Results: We found a significant association between the IL-1 polymorphisms and increased risk for tumor development in patients with intestinal-type gastric carcinoma. A trend towards an increased risk of tumor development was also observed in patients with diffuse-type gastric carcinoma. No significant relationship was observed in patients with atypical carcinoma. Carriers of IL-1B-511T and IL-1RN*2 homozygotes had increased risk for developing intestinal-type gastric carcinoma with odds ratios of 2.7 (95% confidence interval [CI], 1.5-4.9) and 3.1 (95% CI, 1.5-6.5), respectively. Statistical analysis showed an interaction between the 2 loci with the risk conferred by the IL-1B-511T allele substantially increased (odds ratio, 9.0; 95% CI, 3.5-23.0) in individuals homozygous for the IL-1RN*2 allele.

Conclusions: Our results provide further support to the association between IL-1 gene cluster proinflammatory polymorphisms and increased risk of gastric carcinoma. Furthermore, we found evidence pointing to the existence of a synergistic interaction between the IL-1B and IL-1RN polymorphisms.

Citing Articles

Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.

Ding Y, Yi J, Wang J, Sun Z Heliyon. 2023; 9(4):e14960.

PMID: 37025835 PMC: 10070157. DOI: 10.1016/j.heliyon.2023.e14960.


Inflammation and Gastric Cancer.

Jaroenlapnopparat A, Bhatia K, Coban S Diseases. 2022; 10(3).

PMID: 35892729 PMC: 9326573. DOI: 10.3390/diseases10030035.


The Interplay between Tumour Microenvironment Components in Malignant Melanoma.

Amalinei C, Grigoras A, Lozneanu L, Caruntu I, Giusca S, Balan R Medicina (Kaunas). 2022; 58(3).

PMID: 35334544 PMC: 8953474. DOI: 10.3390/medicina58030365.


The Immunogenetics of Melanoma.

Darbeheshti F Adv Exp Med Biol. 2022; 1367:383-396.

PMID: 35286704 DOI: 10.1007/978-3-030-92616-8_15.


Interleukin-1β and Cancer.

Rebe C, Ghiringhelli F Cancers (Basel). 2020; 12(7).

PMID: 32635472 PMC: 7408158. DOI: 10.3390/cancers12071791.